DP Clinical has extensive infectious disease and vaccine experience, and we have conducted numerous Phase I-III studies in various indications. We have worked on studies with healthy volunteers as well as target patient populations, enabling us to anticipate the challenges encountered in these studies and keep them on track. We will help you achieve quality results, meet timelines, and maximize efficiencies by proactively navigating the operational complexities of infectious disease trials.

Whether your study is a small, focused trial or a large, global study; DP Clinical has the knowledge and expertise to make sure our study is a success.

DP Clinical’s infectious disease experience includes Phase I-III studies in the following indications:

  • Aphthous Stomatitis
  • Anthrax
  • Antibiotics
  • Bacteremia
  • Bacterial Infections
  • Bacterial Pneumonia
  • Bone and Joint Infections
  • Community Acquired Pneumonia
  • COVID-19
  • Cryptosporidiosis
  • Gram-negative infections
  • Gram-positive infections
  • Hansen’s Disease (Leprosy)
  • Hepatitis C
  • Malaria
  • Microsporidiosis
  • Norovirus
  • Staphylococcal Aureus-Neonates
  • Staphylococcal Sepsis-Neonates
  • Staphylococcus
  • Vancomycin-Resistant Enterococci (VRE)

DP Clinical’s vaccine experience includes the following indications:

  • Anthrax
  • Influenza
  • Malaria
  • Norovirus
  • Norwalk Virus
  • Pneumonia
  • Zika Virus